ATLAS fair value
ATLAS has no fair value for this stock today.
Green Cross stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Korea Exchange (KOSPI) · South Korea
Prices as of Oct 27, 2026 · KRW
ATLAS has no fair value for this stock today.
50%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Green Cross a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩8,511 and ₩9,595; in 9 out of 10, between ₩7,653 and ₩10,671. Estimated annual volatility is 34%.
ATLAS does not publish a fair value for 005250.KO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 005250.KO has traded between ₩8,630 and ₩18,010. Today it is 49.9% below that high and 5% above its low.
Its beta is 0.56: it tends to move less than the market.
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services.
Want to see everything about Green Cross?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services.
50%: close to a coin flip. In half of the simulated outcomes, 005250.KO ends the month between ₩8,511 and ₩9,595.
Green Cross's market capitalization is ₩407B. We do not show a P/E because it has no positive earnings to base one on.
Yes. 005250.KO's current dividend yield is 3.12% at today's price (₩9,030).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy